Asghar, K., and A. Loya. “INDOLEAMINE 2,3 DIOXYGENASE AS AN IMMUNOTHERAPEUTIC TARGET BRINGS A NEW HOPE FOR CANCER PATIENTS”. Journal of Cancer & Allied Specialties, Vol. 4, no. 3, Sept. 2018, doi:10.37029/jcas.v4i3.175.